Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt Issuances
Ratios

Odyssey Health (ODYY) EBIAT (2016 - 2021)

Odyssey Health has reported EBIAT over the past 8 years, most recently at -$2.9 million for Q3 2021.

  • Quarterly results put EBIAT at -$2.9 million for Q3 2021, down 117.76% from a year ago — trailing twelve months through Jul 2021 was -$16.9 million (down 288.22% YoY), and the annual figure for FY2025 was -$1.7 million, down 106.89%.
  • EBIAT for Q3 2021 was -$2.9 million at Odyssey Health, up from -$12.4 million in the prior quarter.
  • Over the last five years, EBIAT for ODYY hit a ceiling of -$31173.0 in Q1 2017 and a floor of -$23.2 million in Q3 2019.
  • Median EBIAT over the past 5 years was -$247241.0 (2018), compared with a mean of -$2.4 million.
  • Biggest five-year swings in EBIAT: plummeted 23348.43% in 2019 and later skyrocketed 94.26% in 2020.
  • Odyssey Health's EBIAT stood at -$63408.0 in 2017, then fell by 9.6% to -$69496.0 in 2018, then plummeted by 1938.41% to -$1.4 million in 2019, then surged by 49.77% to -$711514.0 in 2020, then tumbled by 307.66% to -$2.9 million in 2021.
  • The last three reported values for EBIAT were -$2.9 million (Q3 2021), -$12.4 million (Q2 2021), and -$869300.0 (Q1 2021) per Business Quant data.